Results 121 to 130 of about 125,156 (180)

Clinical Outcomes of the Germline <i>RET</i> M918T Pathogenic Variant in Hereditary Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. [PDF]

open access: yesMedicina (Kaunas)
Jongthawin J   +6 more
europepmc   +1 more source

Is Calcitonin at 6-12 Months an Appropriate Criterion to Define Cure in Medullary Thyroid Carcinoma? [PDF]

open access: yesWorld J Surg
Ros-Madrid I   +6 more
europepmc   +1 more source

Muir-Torre Syndrome Associated With a Cryptic Intronic MSH2 Variant Identified via Whole-Genome Sequencing: A Case Report. [PDF]

open access: yesPathol Int
Noda K   +13 more
europepmc   +1 more source

Medullary thyroid cancer

Otolaryngologic Clinics of North America, 2003
Medullary thyroid cancer is a rare neoplasm that arises from the parafollicular C cells. It occurs in a sporadic form, or less commonly as a hereditary form, as part of multiple endocrine neoplasia syndromes types 2A and 2B. The RET proto-oncogene is currently the primary factor that is implicated in the hereditary forms of this neoplasm. The knowledge
Gary L, Clayman, Tarek S, el-Baradie
openaire   +2 more sources

Medullary thyroid cancer

Current Treatment Options in Oncology, 2000
Patients with clinically evident medullary thyroid cancer should have a total extracapsular thyroidectomy with bilateral central neck dissection and an ipsilateral prophylactic or therapeutic modified (functional) radical neck dissection when the primary tumor is greater than 1 cm and when the central neck nodes are positive.
E, Kebebew, O H, Clark
openaire   +2 more sources

Home - About - Disclaimer - Privacy